Gastric bypass and sleeve gastrectomy: The same impact on IL-6 and TNF-α. Prospective clinical trial

Obesity Surgery

Volumn 23, Issue 8, 2013, Pages 1252-1261

  Viana, Elaine Cristina ^a,f   Araujo Dasilio, Karine L ^a   Miguel, Gustavo Peixoto Soares ^a   Bressan, Josefina ^b   Lemos, Elenice Moreira ^a   Moyses, Margareth Ribeiro ^a   De Abreu, Gláucia Rodrigues ^a   De Azevedo, João Luiz Moreira Coutinho ^c   Carvalho, Perseu Seixas ^a   Passos Bueno, Maria Rita S ^d   Errera, Flávia Imbroisi Valle ^e   Bissoli, Nazaré Souza ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^f UNIVERSIDADE VILA VELHA   (Brazil)

Author keywords

Bariatric surgery; IL 6; Roux en Y gastric bypass; Sleeve gastrectomy; TNF ; Weight loss

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERLEUKIN 6 GENE; INTERMETHOD COMPARISON; INTRAABDOMINAL FAT; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; SUBCUTANEOUS FAT; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR ALPHA GENE; WOMEN'S HEALTH;

ADULT; BODY MASS INDEX; BRAZIL; FEMALE; GASTRIC BYPASS; GASTROPLASTY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; OBESITY, MORBID; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84879895251     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0894-2     Document Type: Article

References (56)

1. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129-39.
2. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1-16.
3. Frqhbeck G, Salvador J. Role of adipocytokines in metabolism and disease. Nutr Res. 2004;24:803-26.
4. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169-80.
5. World Health Organization - WHO. Global database on body mass index an interactive surveillance tool for monitoring nutrition transition. Available at http://apps.who.int/bmi/index.jsp. Accessed April 5, 2009.
6. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes. 2003;27:S25-8.
7. Wajchenberg BL, Nery M, Cunha MR, et al. Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis. Arq Bras Endocrinol Metab. 2009;53:145-50.
8. Apovian CM, Bigornia S, Mott M, et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol. 2008;28:1654-9.
9. Kern PA, Ranganathan S, Li C, et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:745-51.
10. Fontana MA, Wohlgemuth SD. The surgical treatment of metabolic disease and morbid obesity. Gastroenterol Clin N Am. 2010;39:125-33.
11. Fobi MAL, Lee H. Silastic ring vertical banded gastric bypass for the treatment of obesity: two years of follow up in 84 patients. J Nati Med Assoc. 1994;86:125-8.
12. Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138-44.
13. Gagner M, Deitel M, Kalberer TL, et al. The second international consensus summit for sleeve gastrectomy, March 19-21, 2009. Symposium review. Surg Obes Relat Dis. 2009;5:476-85.
14. 2) population. Obes Surg. 2011;21:1168-71.
15. International Diabetes Foundation (IDF). The IDF consensus worldwide definition of the metabolic syndrome. 2006. Available at http://www.idf.org/ webdata/docs/IDF-Meta-def-final.pdf. Accessed Feb 10, 2012.
16. clinicaltrials.gov (NCT00873405). Banded sleeve gastrectomy versus banded ring gastric bypass in morbidly obese patients. Available at http://clinicaltrials.gov/ct2/show/study/NCT00873405?term = NCT00873405&rank = 1. Accessed April 5, 2009.
17. Miguel GPS, Azevedo JLMC, Souza PHO, et al. Erosive esophagitis after bariatric surgery: banded vertical gastrectomy versus banded Roux-en-Y gastric bypass. Obes Surg. 2011;21:167-72.
18. Jelliffe DB. Evaluación Del estado nutrición de la comunidad. Ginebra: OMS; 1968 (Serie de monografias, 53).
19. World Health Organization (WHO). Obesity. Report of WHO Consultation on Obesity. Geneva, 7-15, 1998.
20. World Health Organization (WHO). Diet, nutrition and the prevention of chronic diseases (DRAFT). Report of WHO Consultation on Obesity. Geneva, 28 January-1 February, 1-54, 2002.
21. Lukaski HC, Johnson PE, Bolonchuk WW, et al. Assessment of fat-free mass using bioeletrical impedance measurements of the human body. Am J Clin Nutr. 1985;41:810-7.
22. Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13:159-60.
23. Sociedade Brasileira de Cirurgia Bariátrica, Colégio Brasileiro de Cirurgiões, Colégio Brasileiro de Cirurgia Digestiva, Sociedade Brasileira de Cirurgia Laparoscópica, Associação Brasileira para o Estudo da Obesidade, Sociedade Brasileira de Endocrinologia e Metabologia. Consenso Brasileiro Multissocietário em Cirurgia da Obesidade. 2006. Available at: http://www.sbcbm.org.br/membros-consenso- bariatrico.php. Access: jan 2010.
24. Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565-8.
25. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;18:3.
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:2002-7.
27. Third report of the National Cholesterol Education Program (NCEP) - Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III) - final report. Circulation 106:3143-421, 2002.
28. Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7:618-24.
29. Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes. 2002;26:659-62.
30. Tice JA, Karliner L, Walsh J, et al. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121:885-93.
31. Kruseman M, Leimgruber A, Zumbach F, et al. Dietary, weight, and psychological changes among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc. 2010;110:527-34.
32. Brethauer AS, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009;5:469-75.
33. Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20:535-40.
34. Bastard J, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000;85:3338-42.
35. Hansen D, Dendale P, Beelen M, et al. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol. 2010;109:397-404.
36. Tchkonia T, Lenburg M, Thomou T, et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab. 2007;292:E298-307.
37. Wolfs MGM, Rensen SS, Bruin-Van Dijk EJ, et al. Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study. BMC Med Genomics. 2010;3:34.
38. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.
39. Baranova A, Collantes R, Gowder SJ, et al. Obesity-related differential gene expression in the visceral adipose tissue. Obes Surg. 2005;15:758-65.
40. Pardina E, Ferrer R, Baena-Fustegueras JA, et al. Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery. Obes Surg. 2012;22:131-9.
41. Gletsu N, Lin E, Zhu J, et al. Increased plasma interleukin 6 concentrations and exaggerated adipose tissue interleukin 6 content in severely obese patients after operative trauma. Surgery. 2006;140(140):50-7.
42. Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Frühbeck G. Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients. Surg Obes Relat Dis. 2011. doi: 10.1016/j.soard.2011.11.001.
43. Kellera M, Mazucha J, Abrahama U, et al. A circadian clock in macrophages controls inflammatory immune responses. PNAS. 2009;106:21407-12.
44. Gustafson B, Gogg S, Hedjazifar S, et al. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab. 2009;297:E999-1003.
45. Peng SC, Wong DSH, Tung KC, et al. Computational modeling with forward and reverse engineering links signaling network and genomic regulatory responses: NF-κB signaling-induced gene expression responses in inflammation. BMC Bioinforma. 2010;11:308-21.
46. Pedersen BK, Febbraio MA. Point: interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol. 2007;102:814-6.
47. Mooney RA. Counterpoint: interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol. 2007;102:816-8.
48. Niesler CU, Prins JB, O'Rahilly S, et al. Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNFa. Int J Obes. 2001;25:1027-33.
49. Brolin RE, Bradley LJ, Wilson AC, et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000;4:464-9.
50. Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010;14:15-23.
51. le Roux CW, Aylwin SJB, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108-14.
52. Hans-Erik J, Arvo H, Margareta O, et al. Alterations in proinsulin and insulin dynamics, HDL cholesterol and ALT after gastric bypass surgery. A 42-months follow-up study. Obes Surg. 2009;19:601-7.
53. Carvalho PS, Moreira CLCB, Barelli MC, et al. Cirurgia Bariátrica Cura Síndrome Metabólica? Arq Bras Endocrinol Metab. 2007;51:79-85.
54. Miguel GPS, Azevedo JLMC, Neto CG, et al. Glucose homeostasis and weight loss in morbidly obese patients undergoing banded sleeve gastrectomy: a prospective clinical study. Clinics. 2009;64:1093-8.
55. Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077-82.
56. Tchkonia T, Lenburg M, Thomou T, et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab. 2007;292:E298-307.